Vanguard Group Inc Adma Biologics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 18,198,796 shares of ADMA stock, worth $337 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,198,796
Previous 18,118,494
0.44%
Holding current value
$337 Million
Previous $362 Million
13.83%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$345 Million0.0% of portfolio
-
State Street Corp Boston, MA14.9MShares$275 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$209 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$102 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.43MShares$100 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.63B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...